[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366315-105":59,"doc-detail-366315-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","molecular-and-genetic-pathogenesis-of-oral-cancer-a-basis-for-customized-diagnosis-and-treatment","Molecular and Genetic Pathogenesis of Oral Cancer - A Basis for Customized Diagnosis and Treatment","","Oral cancer, the most common head and neck malignancy, is a major public health burden characterized by late-stage presentation, poor prognosis, and frequent second primary tumors. Key dysregulated pathways include PI3K/AKT/mTOR, TP53, RB, and WNT/β-catenin, alongside recurrent cytogenetic losses and gains and recurrent gene mutations. Epigenetic changes such as CDKN2A, APC, PTEN and CDH1 methylation alterations and multiple microRNA dysregulations are described. The molecular heterogeneity limits the utility of single biopsies; liquid biopsies using ctDNA, circulating tumor cells, extracellular vesicles or cell-free nucleic acids may enable diagnosis, monitoring and prognostic stratification despite current challenges.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/molecular-and-genetic-pathogenesis-of-oral-cancer-a-basis-for-customized-diagnosis-and-treatment/366315/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/molecular-and-genetic-pathogenesis-of-oral-cancer-a-basis-for-customized-diagnosis-and-treatment/366315.png","ImageObject",300,407,{"name":92,"@type":93},"Pentious","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which signaling pathways are most altered in oral cancer?","Question",{"text":112,"@type":113},"The most altered pathways include PI3K/AKT/mTOR, TP53, RB, and WNT/β-catenin.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What genetic and cytogenetic changes are frequently reported in oral cancer?",{"text":117,"@type":113},"Frequent cytogenetic losses occur at 3p, 8p, 9p and 18q, with gains at 3q, 7p, 8q and 11q, and recurrent mutations in several cancer-related genes such as TP53, EGFR and PI3K-related components are described.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are liquid biopsies considered a promising alternative to single biopsies?",{"text":121,"@type":113},"Oral tumors show genetic heterogeneity and dynamic evolution, so a single biopsy may not capture the full set of actionable molecular targets; liquid biopsies can provide a less invasive way to monitor progression and identify targets.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366315,1790445518,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review  \nMolecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment  \nLeonor Barroso 1,†, Pedro Veiga 2,†, Joana Barbosa Melo 2,3,4, Isabel Marques Carreira 2,3,4  \nand Ilda Patrícia Ribeiro 2,3,4, *  \nAcademic Editor: Dirk Rades  \nReceived: 12 June 2025  \nRevised: 7 July 2025  \nAccepted: 9 July 2025  \nPublished: 10 July 2025  \nCitation: Barroso, L.; Veiga, P.; Melo, J.B.; Carreira, I.M.; Ribeiro, I.P. Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment. Biology 2025, 14, 842. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biology14070842  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Maxillofacial Surgery Department, Unidade Local de Saúde de Coimbra, 3000-075 Coimbra, Portugal; [leonor.barroso@gmail.com](leonor.barroso@gmail.com)  \n2 Institute of Cellular and Molecular Biology, Cytogenetics and Genomics Laboratory, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal; [mmelo@fmed.uc.pt](mmelo@fmed.uc.pt) (J.B.M.);  \n[icarreira@fmed.uc.pt](icarreira@fmed.uc.pt) (I.M.C.)  \n3 Coimbra Institute for Clinical and Biomedical Research (iCBR) and Center of Investigation on Environment Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal  \n4 Center for Innovative Biomedicine and Biotechnology (CIBB) and Clinical Academic Center of Coimbra (CACC), University of Coimbra, 3000-548 Coimbra, Portugal  \n* Correspondence: [iribeiro@uc.pt](iribeiro@uc.pt)  \n† These authors contributed equally to this work.  \nSimple Summary  \nOral cancer is the most common form of head and neck cancer and remains a serious global health concern; it is often diagnosed at advanced stages and is associated with poor prognosis. Treatment is still based on surgery, radiation, and chemotherapy, and despite advances in targeted therapies and immunotherapy, the prognosis is still poor. Multiple genetic and epigenetic alterations have been identified, including changes in key signaling pathways such as PI3K/AKT/mTOR, TP53, and WNT/β-catenin. Genomic studies have revealed frequent chromosomal gains and losses, mutations in several cancer-related genes, and deregulated microRNAs. Despite this growing molecular knowledge, its application in clinical practice is still limited, with cetuximab being one of the few targeted therapies currently used. Due to the genetic heterogeneity of oral tumors and their dynamic evolution, single biopsies may not provide a complete picture. In this context, liquid biopsies offera promising, less invasive alternative for monitoring disease progression and identifying therapeutic targets. We critically review the current knowledge on the molecular, genetic, and epigenetic alterations in oral cancer, as well as the applications and challenges of liquid biopsies in its diagnosis, follow-up, and prognostic stratification.  \nAbstract  \nOral cancer, the most common form of head and neck cancer, is worldwide a serious public health problem. Most patients present a locally advanced disease, and face poor prognosis, even with multimodality treatment. They may also develop second primary tumors in the entirety of their upper aerodigestive tract. The most altered signaling pathways are the PI3K/AKT/mTOR, TP53, RB, and the WNT/β-catenin pathways. Genomic and molecular cytogenetic analyses have revealed frequent losses at 3p, 8p, 9p, and 18q, along with gains at 3q, 7p, 8q, and 11q, and several genes frequently affected have been identified, such as TP53, CCND1, CTTN, CDKN2A, EGFR, HRAS, PI3K, ADAM9, MGAM, SIRPB1, and FAT1, among others. Various epigenetic alterations were also","cbCaigBSdScT27Iz","https://ap.wps.com/l/cbCaigBSdScT27Iz","pdf",1052484,23,"English","# Abstract\n# 1. Clinical Aspects of Oral Cancer\n## 1.1. Epidemiology\n# 2. Molecular and Genetic Alterations in Oral Cancer\n## 2.1. Signaling Pathways\n## 2.2. Genomic and Cytogenetic Findings\n## 2.3. Epigenetic and microRNA Dysregulation\n# 3. Liquid Biopsies in Oral Cancer\n## 3.1. Applications in Diagnosis and Follow-up\n## 3.2. Prognostic and Staging Potential\n## 3.3. Challenges and Limitations","[{\"question\":\"Which signaling pathways are most altered in oral cancer?\",\"answer\":\"The most altered pathways include PI3K/AKT/mTOR, TP53, RB, and WNT/β-catenin.\"},{\"question\":\"What genetic and cytogenetic changes are frequently reported in oral cancer?\",\"answer\":\"Frequent cytogenetic losses occur at 3p, 8p, 9p and 18q, with gains at 3q, 7p, 8q and 11q, and recurrent mutations in several cancer-related genes such as TP53, EGFR and PI3K-related components are described.\"},{\"question\":\"Why are liquid biopsies considered a promising alternative to single biopsies?\",\"answer\":\"Oral tumors show genetic heterogeneity and dynamic evolution, so a single biopsy may not capture the full set of actionable molecular targets; liquid biopsies can provide a less invasive way to monitor progression and identify targets.\"}]","Molecular and Genetic Pathogenesis of Oral Cancer - A Basis for Customized Diagnosis and Treatment | PDF",1790164740,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7aa614bc3be7dca37b26284238a29d94.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9df4ef6514fa30e41549b9b6c36fbfa.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83d65d86f36500680924c6697eded119.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d92a000bc9d26ec2f52ffd5a5c8a100.webp",980,1385]